📰 Jeff Borcherding News
Jeff Borcherding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jeff Borcherding. Real-time updates on events, politics, business and more.
May 21, 2024
/PRNewswire/ -- The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today, subject to approval by the Annual General Meeting on 19...
May 21, 2024
/PRNewswire/ -- The shareholders in Immunovia AB (publ), Reg. No. 556730-4299, are hereby invited to the Annual General Meeting ("AGM") to be held at The...
May 21, 2024
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE,
May 20, 2024
The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today,...
April 23, 2024
/PRNewswire/ -- Immunovia will publish its first quarter 2024 results on April 29, 2024 at 8:30 am CET. Analysts, investors and media are invited to a webcast...
April 9, 2024
/PRNewswire/ -- Immunovia (NASDAQ: IMMNOV) (STO: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early...
February 21, 2024
/PRNewswire/ -- October-December 2023 Net sales, which for the quarter only included royal- ties, amounted to kSEK 155 (502). Net earnings were MSEK -49 (-67)...
November 9, 2023
During the third quarter we made significant changes to streamline Immunovia and made important progress in...
November 9, 2023
/PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488 (358) divided by sales of tests KSEK 70 (111) and royalties KSEK 418 (247). Net earnings...
November 9, 2023
During the third quarter we made significant changes to streamline Immunovia and made important progress in...